Improved diagnostic imaging and interventional therapies prolong survival after resection for hepatocellular carcinoma in cirrhosis: The university of Bologna experience over 10 years

Annals of Surgical Oncology

Volumn 18, Issue 6, 2011, Pages 1630-1637

  Cucchetti, Alessandro ^a   Zanello, Matteo ^a   Cescon, Matteo ^a   Ercolani, Giorgio ^a   Del Gaudio, Massimo ^a   Ravaioli, Matteo ^a   Grazi, Gian Luca ^a   Pinna, Antonio D ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM;

ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILD; CONTRAST RADIOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRESCHOOL CHILD; RECURRENCE RISK; REPEAT PROCEDURE; ROMANIA; SALVAGE THERAPY; SCHOOL CHILD; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TERTIARY HEALTH CARE;

CARCINOMA, HEPATOCELLULAR; DIAGNOSTIC IMAGING; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 79956191452     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1463-8     Document Type: Article

References (38)

1. HB El-Serag JA Davila NJ Petersen KA McGlynn 2003 The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update Ann Intern Med 139 817 823 14623619
2. J Thompson Coon G Rogers P Hewson, et al. 2007 Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis Health Technol Assess 11 1 206 17767898 1:STN:280:DC%2BD2srhslamug%3D%3D
3. G Torzilli M Makuuchi K Inoue, et al. 1999 No-mortality liver resection for hepatocellular carcinoma in cirrhotic and non-cirrhotic patients: is there a way? A prospective analysis of our approach Arch Surg 134 984 992 10487594 10.1001/archsurg.134.9.984 1:STN:280:DyaK1MvhsFGgtw%3D%3D (Pubitemid 29428911)
4. GL Grazi G Ercolani F Pierangeli, et al. 2001 Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value Ann Surg 234 71 78 11420485 10.1097/00000658-200107000-00011 1:STN:280:DC%2BD3MzlvFChtg%3D%3D (Pubitemid 32619337)
5. RT Poon ST Fan IO Ng, et al. 2000 Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma Cancer 89 500 507 10931448 10.1002/1097-0142(20000801)89:3<500:: AID-CNCR4>3.0.CO;2-O 1:STN:280:DC%2BD3cvgt1aktg%3D%3D (Pubitemid 30640096)
6. H Imamura Y Matsuyama E Tanaka, et al. 2003 Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy J Hepatol 38 200 207 12547409 10.1016/S0168-8278(02)00360-4 (Pubitemid 36169630)
7. N Portolani A Coniglio S Ghidoni, et al. 2006 Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications Ann Surg 243 229 235 16432356 10.1097/01.sla.0000197706.21803.a1 (Pubitemid 43185442)
8. A Cucchetti F Piscaglia E Caturelli, et al. 2009 Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population Ann Surg Oncol 16 413 422 19034578 10.1245/s10434-008-0232-4
9. RT Poon ST Fan CM Lo CL Liu J Wong 2002 Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation Ann Surg 235 373 382 11882759 10.1097/00000658-200203000-00009 (Pubitemid 34183888)
10. JM Llovet J Bruix 2003 Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 429 442 12540794 10.1053/jhep.2003.50047 1:CAS:528: DC%2BD3sXhsFeltrg%3D (Pubitemid 36152543)
11. R Lencioni L Crocetti P De Simone Fl Filipponi 2010 Loco-regional interventional treatment of hepatocellular carcinoma: techniques, outcomes, and future prospects Transpl Int 23 698 703 20492618 10.1111/j.1432-2277.2010.01109. x
12. M Sherman 2007 Screening for hepatocellular carcinoma Hepatol Res 37 Suppl 2 S152 S165 17877478 10.1111/j.1872-034X.2007.00180.x
13. F Trevisani S De Notaris G Rapaccini 2002 et al., Italian Liver Cancer Group. Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience) Am J Gastroenterol 97 734 744 11922571 10.1111/j.1572-0241.2002. 05557.x (Pubitemid 34245906)
14. V Santi F Trevisani A Gramenzi, et al. 2010 Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival J Hepatol 53 291 297 20483497 10.1016/j.jhep.2010.03.010
15. A Cucchetti G Ercolani M Vivarelli, et al. 2009 Is portal hypertension a contraindication to hepatic resection? Ann Surg 250 922 928 19855258 10.1097/SLA.0b013e3181b977a5
16. M Cescon A Cucchetti GL Grazi, et al. 2009 Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables Arch Surg 144 57 63 19153326 10.1001/archsurg.2008.522
17. K Ishak A Baptista L Bianchi, et al. 1995 Histological grading and staging of chronic hepatitis J Hepatol 22 696 699 7560864 10.1016/0168-8278(95) 80226-6 1:STN:280:DyaK28%2FjsFWntw%3D%3D
18. RN Pugh IM Murray-Lyon JL Dawson MC Pietroni R Williams 1973 Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 646 649 4541913 10.1002/bjs.1800600817 1:STN:280:DyaE3s3jsVWqsw%3D%3D
19. RH Wiesner SV McDiarmid PS Kamath, et al. 2001 MELD and PELD: application of survival models to liver allocation Liver Transpl 7 567 580 11460223 10.1053/jlts.2001.25879 1:STN:280:DC%2BD3MvhtFyntA%3D%3D (Pubitemid 32677880)
20. JM Llovet C Brù J Bruix 1999 Prognosis of hepatocellular carcinoma: the BCLC staging classification Semin Liver Dis 19 329 338 10518312 10.1055/s-2007-1007122 1:STN:280:DyaK1Mvks1Grsg%3D%3D
21. JA Melendez V Arslan ME Fischer, et al. 1998 Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction J Am Coll Surg 187 620 625 9849736 10.1016/S1072-7515(98)00240-3 1:STN:280: DyaK1M%2FmsV2rug%3D%3D (Pubitemid 28557801)
22. Committee of the International Hepato-Pancreato-Biliary Association. IHPBA Brisbane. Terminology of liver anatomy and resections, vol. 2. Abingdon, UK: Taylor & Francis; 2000. p. 333-9
23. United Network for Organ Sharing Policy 3.6.4.4. Available at: http://www.unos.org. Accessed May 1, 2010.
24. American Joint Committee on Cancer. AJCC cancer staging manual. 6th ed. New York: Springer; 2002.
25. D Dindo N Demartines PA Clavien 2004 Classification of surgical complications-a new proposal with evaluation in a cohort of 6336 patients and results of a survey Ann Surg 240 205 213 15273542 10.1097/01.sla.0000133083. 54934.ae (Pubitemid 38963009)
26. JM Llovet S Ricci V Mazzaferro, et al. 2008 SHARP Investigator Study Group. Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 378 390 18650514 10.1056/NEJMoa0708857 1:CAS:528:DC%2BD1cXovFWjsL8%3D
27. AL Cheng YK Kang Z Chen, et al. 2009 Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial Lancet Oncol 10 25 34 19095497 10.1016/S1470-2045(08)70285-7 1:CAS:528:DC%2BD1cXhsFChtbnM
28. IO Ng XY Guan RT Poon ST Fan JM Lee 2003 Determination of the molecular relationship between multiple tumour nodules in hepatocellular carcinoma differentiates multicentric origin from intrahepatic metastasis J Pathol 199 345 353 12579536 10.1002/path.1287 1:CAS:528:DC%2BD3sXis1ekuro%3D (Pubitemid 36266857)
29. YJ Chen SH Yeh JT Chen, et al. 2000 Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma Gastroenterology 119 431 440 10930378 10.1053/gast.2000.9373 1:STN:280:DC%2BD3cvgtl2kug%3D%3D
30. SD Finkelstein W Marsh AJ Demetris, et al. 2003 Microdissection-based allelotyping discriminates de novo tumor from intrahepatic spread in hepatocellular carcinoma Hepatology 37 871 879 12668980 10.1053/jhep.2003.50134 1:CAS:528:DC%2BD3sXjt1Wlurs%3D (Pubitemid 36397398)
31. JD Schwartz M Schwartz J Mandeli M Sung 2002 Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials Lancet Oncol 3 593 603 12372721 10.1016/S1470-2045(02)00873-2 (Pubitemid 35174678)
32. RT Poon ST Fan CM Lo CL Liu J Wong 1999 Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors Ann Surg 229 216 222 10024103 10.1097/00000658-199902000- 00009 1:STN:280:DyaK1M7ks1Ojug%3D%3D (Pubitemid 30191795)
33. M Shimada K Takenaka K Taguchi, et al. 1998 Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma Ann Surg 227 80 85 9445114 10.1097/00000658-199801000-00012 1:STN:280:DyaK1c7gsFymuw%3D%3D (Pubitemid 28071341)
34. M Minagawa M Makuuchi T Takayama N Kokudo 2003 Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma Ann Surg 238 703 710 14578733 10.1097/01.sla.0000094549.11754.e6 (Pubitemid 38182262)
35. A Cucchetti A Vitale M Del Gaudio, et al. 2010 Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma Am J Transplant 10 619 627 20121741 10.1111/j.1600-6143.2009.02984.x 1:STN:280:DC%2BC3c3osVylsw%3D%3D
36. OPTN 2008 annual report. Available at: http://www.optn.org/data/ annualReport.asp. Accessed May 1, 2010.
37. R Adam P McMaster JG O'Grady, et al. 2003 Evolution of liver transplantation in Europe: report of the European Liver Transplant Registry Liver Transpl 9 1231 1243 14625822 10.1016/j.lts.2003.09.018 (Pubitemid 37536793)
38. JH Wang CS Changchien TH Hu, et al. 2008 The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma-survival analysis of 3892 patients Eur J Cancer 44 1000 1006 18337087 10.1016/j.ejca.2008.02.018